Pharm Flashcards
Half life eqn
t(half)=0.7*Vd/CL
Volume of distribution eqn
Vd=amt in body/plasma conc
Clearance eqn
CL=rate of elimination/plasma conc
Loading dose eqn
LD=Cp*(Vd/F)
Cp=target plasma conc
Maintenance dose eqn
MD=Cp*CL/F
Half lives to reach steady state
4-5
Action of competitive antagonist
decreases potency
Action of noncompetitive antagonist
decrease efficacy
Nicotinic receptors
ACh
Na+/K+ channels
Nn on autonomic ganglia
Nm on NMJ
Muscarinic receptors
ACh G protein coupled M1-CNS, Gq M2-heart, Gi M3-smooth m., endocrine, accomodation, Gq
D1 receptor
relaxes renal vascular smooth m.
D2 receptor
modulates CNS neurotransmitters
Bethanechol use
activates bowel/bladder smooth m.
ACh agonist
Carbachol use
glaucoma/decreases intraocular P
Ach agonist
Pilocarpine use
open and closed angle glaucoma
contracts ciliary m. and pupillary sphincter
Uses of anticholintesterases
Myasthenia gravis/anticholinergic toxicity
Neostigmine/pyridostigmine
edrophonium/physostigmine/donepezil
Use for physostigmine
anticholinergic toxicity
crosses BBB
Use of donepezil
Alzheimer’s disease
anticholinesterase action
Antidote for anticholinergic agents
atropine + pralidoxime